Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Medication-Assisted Treatment for Opioid Use Disorder ...
Released: November 30, 2018
On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the dissemination of accurate patient-focused information about treatments for opioid use disorder, and to help provide scientific solutions to the current opioid crisis, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine was created to conduct a study of the evidence base on Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD).
Harnessing Mobile Devices for Nervous System Disorders ...
Released: November 19, 2018
To explore current developments and opportunities for using mobile technology to advance research and treatment of central nervous system (CNS) disorders, the National Academies’ Forum on Neuroscience and Nervous System Disorders hosted a workshop on June 5–6, 2018.
Integrating Responses at the Intersection of Opioid Use ...
Released: July 13, 2018
The opioid epidemic is changing the epidemiology of HIV, hepatitis, and other infectious disease. To address the infectious disease consequences of the opioid crisis, a public workshop titled Integrating Infectious Disease Considerations with Response to the Opioid Epidemic was convened on March 12 and 13, 2018.
Neuroforensics: Exploring the Legal Implications of Emerging ...
Released: July 06, 2018
On March 6, 2018, the Forum on Neuroscience and Nervous System Disorders, in collaboration with the Committee on Science, Technology, and Law (CSTL), held a public workshop to explore and advance efforts to identify and evaluate the potential effects of emerging neurotechnologies on the legal system.
Identifying the Role of Violence and Its Prevention in the Post ...
Released: April 06, 2018
The post-2015 Sustainable Development Goals (SDGs) set out 17 specific goals and 169 associated targets across the social, economic, and environmental dimensions of sustainable development, all to be achieved by 2030. The SDGs include the prevention of violence and have several targets that address the underlying causes of violence as well as targets that address such risk factors as poverty, alcohol misuse, social protection, and justice.
Addressing the Social and Cultural Norms That Underlie the ...
Released: April 06, 2018
To better understand how social and cultural norms are related to violence and violence prevention, the Forum on Global Violence Prevention convened a workshop1on October 29–30, 2015, to explore the social and cultural norms that underlie the acceptance of violence, with a focus on violence against women across the lifespan, violence against children, and youth violence.
The Neurocognitive and Psychosocial Impacts of Violence ...
Released: April 06, 2018
Childhood experiences, both positive and negative, can affect an individual’s health and opportunities as an adult and have far-reaching effects on future violence victimization and perpetration. To better understand the impacts of violence and trauma on neurocognitive functions and psychosocial well-being, the Forum on Global Violence Prevention convened a 2-day workshop July 31– August 1, 2017.
Advancing Therapeutic Development for Pain and Opioid Use ...
Released: March 23, 2018
Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. In parallel with increasing recognition of the need to treat chronic pain, the opioid epidemic has emerged as a growing public health emergency. In 2017, the National Institutes of Health began exploring public-private partnerships to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To help inform this effort, the National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together experts and stakeholders from academia, federal agencies, advocacy organizations, and companies developing therapeutics for pain and opioid use disorders.
Violence and Mental Health: Opportunities for Prevention and ...
Released: March 22, 2018
On February 26–27, 2014, the National Academies of Sciences, Engineering, and Medicine’s Forum on Global Violence Prevention convened a workshop titled Mental Health and Violence: Opportunities for Prevention and Early Intervention. The workshop brought together advocates and experts in public health and mental health, anthropology, biomedical science, criminal justice, global health and development, and neuroscience to examine experience, evidence, and practice at the intersection of mental health and violence.
Enabling Novel Treatments for Nervous System Disorders by ...
Released: March 08, 2018
The blood-brain barrier (BBB) presents a special challenge to the development of therapeutics for many central nervous system (CNS) disorders. Far from acting simply as a physical barrier, the BBB is a complex dynamic system involving several cell types, passive and active transport mechanisms, and adaptive function to control the exchange of substances between the blood and the CNS. Few therapeutic agents readily traverse the BBB to reach the brain or spinal cord, including most small molecule drugs and the vast majority of large molecules such as proteins.